The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension.
M W Geraci; B Gao; D C Shepherd; M D Moore; J Y Westcott; K A Fagan; L A Alger; R M Tuder; N F Voelkel (Profiled Author: Rubin Tuder)
Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, Pulmonary Hypertension Center, University of Colorado Health Sciences, Center, Denver, CO, USA. firstname.lastname@example.org
The Journal of clinical investigation 1999;103(11):1509-15.
Prostacyclin synthase (PGIS) is the final committed enzyme in the metabolic pathway leading to prostacyclin (PGI2) production. Patients with severe pulmonary hypertension have a PGIS deficiency of their precapillary vessels, but the importance of this deficiency for lung vascular remodeling remains unclear. We hypothesized that selective pulmonary overexpression of PGIS may prevent the development of pulmonary hypertension. To study this hypothesis, transgenic mice were created with selective pulmonary PGIS overexpression using a construct of the 3.7-kb human surfactant protein-C (SP-C) promoter and the rat PGIS cDNA. Transgenic mice (Tg+) and nontransgenic littermates (Tg-) were subjected to a simulated altitude of 17,000 ft for 5 weeks, and right ventricular systolic pressure (RVSP) was measured. Histology was performed on the lungs. The Tg+ mice produced 2-fold more pulmonary 6-keto prostaglandin F1alpha (PGF1alpha) levels than did Tg- mice. After exposure to chronic hypobaric hypoxia, Tg+ mice have lower RVSP than do Tg- mice. Histologic examination of the lungs revealed nearly normal arteriolar vessels in the Tg+ mice in comparison with vessel wall hypertrophy in the Tg- mice. These studies demonstrate that Tg+ mice were protected from the development of pulmonary hypertension after exposure to chronic hypobaric hypoxia. We conclude that PGIS plays a major role in modifying the pulmonary vascular response to chronic hypoxia. This has important implications for the pathogenesis and treatment of severe pulmonary hypertension.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
R M Tuder; C D Cool; M W Geraci; J Wang; S H Abman; L Wright; D Badesch; N F VoelkelAmerican journal of respiratory and critical care medicine 1999;159(6):1925-32.
R M Tuder; C D Cool; M Yeager; L Taraseviciene-Stewart; T M Bull; N F VoelkelClinics in chest medicine 2001;22(3):405-18.
Manik C Ghosh; De-Liang Zhang; Suh Young Jeong; Gennadiy Kovtunovych; Hayden Ollivierre-Wilson; Audrey Noguchi; Tiffany Tu; Thomas Senecal; Gabrielle Robinson; Daniel R Crooks; et al.Cell metabolism 2013;17(2):271-81.
Appears in this Publication
Author of this Publication